Building Tomorrow’s Cannabis System
Join the global plant-based medicine revolution as we create a healthier, wealthier future for the planet, humanity, your family and you
As seen on
The Origin Story
Byron Bay Bio is an Australian company advancing innovation in cannabis research and product development with a mission to create and supply high-quality cannabis products while respecting the industry’s pioneering legacy and regulatory compliance.
Our Brands
Who We Are
Byron Bay Bio is an Australian company advancing innovation in cannabis research and product development with a mission to create and supply high-quality cannabis products while respecting the industry’s pioneering legacy and regulatory compliance. We manage a diverse portfolio of cannabis investments across Australia, USA and Europe, combining cutting-edge agricultural science and processing technology with plant-based medicine for supply of holistic natural health products.
BUILDING A CANNABIS ECOSYSTEM FOR HOLISTIC NATURAL HEALTH PRODUCTS
What makes our approach unique is our innovative work in cannabis DNA genomics and characterisation as well as intellectual property protection of plant breeder rights. Through our Byron Bay Biotech division, we collaborate with the world’s leading scientific research centres to explore and patent cannabis strains, utilising proprietary technology for precise identification of key traits and characteristics. This proprietary technology not only safeguards valuable cannabis strains but also sets new standards for product quality and safety across the industry.
Who We Are
Our Vision
We believe humanity is on the cusp of a global cannabis health revolution, driven by shifting consumer attitudes towards plant medicines and increased public awareness of modern, natural health practices with holistic natural plant compounds over synthetised chemical pharmaceuticals. Our vision is to drive change as a global leader in the design, development, and distribution of the highest quality natural cannabis products.
This future is shaped by genetic science and standardisation technology, enabling a deeper understanding of cannabis strains and their potential applications in health and wellness. We envision a world where cultivator innovation is safeguarded, medicinal efficacy is guaranteed through genetic verification, and the full potential of cannabis genetics is realised through rigorous scientific advancement
Our Science
Byron Bay Bio is committed to scientific research and analysis of cannabis and other plants to provide natural holistic health and wellness products. Byron Bay Bio’s innovative approach to cannabis standardisation leverages certified scientific laboratory testing of cannabis genomics and phenomics combined with precise digital chemical analysis to identify variations in over 500 compounds present in cannabis and any residual toxic chemicals and foreign organisms.
With this commitment we go beyond the surface level testing that is common in the CBD and pharmaceutical markets to ensure all Byron Bay Bio brands are superior to the competition
Our Team
Our executive teams proven corporate management and commercialisation expertise enables Byron Bay Bio to focus on the immense potential of the cannabis industry that is projected to climb at an impressive 28% CAGR in 2025. By uniting strategic vision, rigorous risk oversight, and innovative brand leadership, we navigate evolving regulations and unlock new market opportunities. This dynamic synergy propels strong revenue growth and maximizes ROI, ensuring investors benefit from a robust, future-focused approach in the cannabis industry one of the most rapidly expanding global sectors.
Jeff Lang
CEO and Executive Director Jeff is an experienced CEO, Executive and Board Director with expertise in start-up companies.
Will Stolk
Business Development Manager William is world renown Cannabis Activist and founder of the Byron Bay Bio company.
Shaye Harty
General Manager With proven expertise in business operations, consensus-based leadership, and holistic health...
Our Science
Byron Bay Bio is committed to scientific research and analysis of cannabis and other plants to provide natural holistic health and wellness products. Byron Bay Bio’s innovative approach to cannabis standardisation leverages certified scientific
laboratory testing of cannabis genomics and phenomics combined with precise
digital chemical analysis to identify variations in over 500 compounds present in
cannabis and any residual toxic chemicals and foreign organisms. With this commitment we go beyond the surface level testing that is common in the CBD and pharmaceutical markets to ensure all Byron Bay Bio brands are superior to the
competition.
Brands Portfolio
Byron Bay Bio group holdings invests in diverse companies and assets within the cannabis, biotech, and wellness sectors. Our portfolio spans multiple industries, reflecting our commitment to innovation, sustainability, and market adaptability.
Rapid FX represents a new era of plant-based recovery solutions, combining medical grade CBD with natural botanical compounds. Our premium range of muscle balms, oils, and tablets harnesses cutting-edge extraction technology to deliver superior…
Award-winning cannabis strains for the cannabis connoisseurs.
Your trusted source for innovative, wellness-focused
cannabis solutions.
Pioneering cannabis genomics for medical
health breakthroughs.
Investors
New Investors
If you are not a shareholder yet and would like to express your interest in investing.
News
Discover Byron Bay Bio media press release archives
Join Our Newsletter
Stay informed with the latest news, insights, and exclusive updates delivered to your inbox.